Design and Baseline Patient Characteristics of the Prospective, Observational, Multicenter and Multinational Cohort Study Comparing Radiofrequency with Cryoablation for Pulmonary Vein Isolation in Patients with Atrial Fibrillation—The Freeze Cohort Study

作     者：Ellen Hoffmann Uwe Dorwarth Karl Heinz Kuck Jürgen Vogt Malte Kuniss Steffen Schneider Jürgen Tebbenjohanns Kyong Ryul Julian Chun Dietrich Andresen Stefan Spitzer Thorsten Lewalter Stephan Willems Johannes Brachmann Christoph Stellbrink Bernhard Rauch Jochen Senges 

作者机构：Department of Cardiology Klinikum Bogenhausen Munich Germany Department of Cardiology Asklepios Klinik St. Georg Hamburg Germany Ruhr University Bochum Bad Oeynhausen Germany Department of Cardiology Kerckhoff Klinik Bad Nauheim Germany Stiftung Institut für Herzinfarktforschung Ludwigshafen am Rhein Germany Klinikum Hildesheim Hildesheim Germany Center for Cardiology and Angiology Frankfurt CCB Frankfurt am Main Germany Department of Cardiology Vivantes Klinikum am Urban Berlin Germany Praxisklinik Herz und Gefäße Dresden Germany Department of Cardiology Isar Herzzentrum Munich Germany Department of Cardiology Universitäres Herzzentrum Hamburg Hamburg Germany Department of Cardiology Klinikum Coburg Coburg Coburg Department of Cardiology Klinikum Bielefeld Bielefeld Germany 

出 版 物：《International Journal of Clinical Medicine》 (临床医学国际期刊（英文）)

年 卷 期：2014年第5卷第19期

页      面：1161-1172页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Atrial Fibrillation Catheter Ablation Cryoballoon Ablation Radiofrequency Ablation Registry 

摘      要：Aims: The FREEZE-cohort study (NCT 01360008) is a prospective observational, multicenter and multinational study to evaluate safety and effectiveness of cryoballoon ablation for pulmonary vein isolation as compared to radiofrequency ablation in patients with paroxysmal or persistent atrial fibrillation (lasting one year) under the conditions of clinical routine. Methods and Results: The study started in 2011 and anticipates inclusion up to 2000 patients in each of the two treatment groups. A total of 37 centers from 8 countries worldwide, all experienced in at least one of the two ablation techniques, participate in the study. The primary outcome parameter of the study is defined as atrial fibrillation recurrence rate during twelve months of follow-up. Secondary outcome parameters include primary success rates, complication rates in general, specific complications with respect to phrenic nerve palsy and pulmonary vein stenosis, radiation exposure, clinical course including death and repeat ablation. Finally specific procedural aspects will be evaluated in a descriptive manner. Preliminary data of the first 1882 patients show that in clinical practice cryoablation is preferentially performed in patients with paroxysmal atrial fibrillation, whereas application of radiofrequency ablation is equally distributed between patients with persistent and paroxysmal atrial fibrillation. Conclusion: Based on multi-center and multi-national data the FREEZE-cohort study will provide important information on long-term efficacy, clinical effectiveness, complication rates and procedural differences between atrial fibrillation patients treated with either cryoablation or radiofrequency ablation.